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ABSTRACT 
Introduction: Cervical cancer is one of the few preventable cancers. Health education 
messages about the cancer and its prevention should form part of the prevention strategies. 
Assessing knowledge about various aspects of the cancer has an important role in determining 
knowledge gaps that exist and therefore helps in designing health education messages about the 
cancer.    
Sexual behaviour has been shown to play a major role in determining risk of contracting 
Human papillomavirus (HPV) and of developing cervical cancer. 
 This study was designed  to  assess  knowledge of HPV, HPV vaccine, cervical  cancer and its 
correlates, and to assess sexual  practices  among  female  students  at the University  of  
Witwatersrand.  
Methods: This was a descriptive cross-sectional study. Data was collected using a self-
administered questionnaire that was administered in female residences and analysed using the 
STATA 10 statistical package. 
Results: A total of 860 questionnaires were distributed in 4 female residences. Amongst these, 
190 questionnaires were completed. Awareness of cervical cancer was high (95%) but 
knowledge of its risk factors and preventive measures was low. Only 43% and 27% of the 
respondents had knowledge about HPV and HPV vaccine respectively. Although only 47% of 
the respondents were sexually active, sexual behaviour  that  would  put  these  women  at  risk  
for contracting HPV infection and cervical  cancer namely, high numbers of sexual partners, 
early age of coitarche and inconsistent condom use were present among those that were  
sexually active. 
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Conclusion: Risk factors for cervical cancer and gaps in knowledge about cervical cancer, 
HPV and HPV vaccine exist among this population and there is need for further health 
education. 
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1. INTRODUCTION 
 
1.1. BACKGROUND 
Cervical cancer is a major health problem in developing countries. The prevention of this 
cancer is currently dependent on the use of cervical cytology as a means to recognise 
premalignant change (1). Human Papillomavirus (HPV) has been identified as central to 
premalignant change and cancer development (2) and the HPV vaccine is a possible prevention 
strategy(3). Assessment of knowledge about HPV, HPV vaccines and cervical cancer amongst 
South African women is therefore important for possible cervical cancer prevention. 
The  relationship  between  sexual  behaviour,  HPV  infection  and  risk  of  developing    
cervical  cancer  has  been well documented (4). Assessing  sexual  behaviour  amongst South 
African women would not only allow that risk factors for cervical cancer be identified amongst 
these women, but also the implementation of strategies to minimise, or hopefully eliminate 
these risk factors.  
According to the World Health Organisation (WHO), cancer of the cervix is the leading cause 
of gynaecological related deaths worldwide. It is the commonest cancer among women in 
developing countries, and the second commonest cancer worldwide in women. Women in   
developing countries account for about 85% of both annual cases of cervical cancer (estimated 
at 493,000) and annual deaths from cervical cancer (estimated at 273,500). According to a 
2002 WHO report, the crude incidence rate of cancer of the cervix in South Africa is 
30.2/100,000 women per year (5). 
HPV is the commonest sexually transmitted disease. Approximately 75-80% of sexually active  
women will be infected with HPV at some point in their lifetime (6).There are over 100 known  
serotypes of this virus and about 40 of these are thought to infect the genital tract (7). It is 
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known that infection of the genital tract with HPV leads to a range of states from asymptomatic 
carriage of the virus, genital warts, cervical dysplasia to cervical carcinoma (7). 
Epidemiological studies suggest that at least 15 of the HPV genital tract serotypes, called high 
risk types, are significantly associated with progression to invasive carcinoma of the cervix (8). 
Persistent HPV infection is implicated in 99.7% of all cervical cancers (2). The low risk 
serotypes are associated with development of genital warts and low grade squamous intra-
epithelial lesions (LGSIL) of the cervix.  The commonest of these high risk serotypes are HPV 
16 and 18 while 6 and 11 are the commonest of the low risk serotypes (8).  
Highest rates of HPV infection are said to be found in the 18-28 year age group, most likely 
because sexual debut often occurs in mid to late teens and HPV exposure usually occurs at this 
time. These infections invariably are transient (6).   
Invasive cancer of the cervix is one of the few preventable cancers. These preventive strategies 
include primary and secondary. Primary preventative measures include issues of lifestyle 
modification to eliminate risk factors for cervical cancer such as commencing sexual activity at 
an early age, promiscuity (4) and smoking (9). Primary prevention can also be achieved by the 
use of Human Papillomavirus (HPV) vaccines (3). Currently there are 2 vaccines available, a  
quadrivalent vaccine against HPV 6, 11, 16 and 18, Gardasil, and Cervarix, which  is a bivalent 
vaccine against HPV 16 and 18. The Centre for Disease Control and Prevention (CDC) 
Advisory Committee on Immunisation Practices (ACIP) recommended routine HPV  
vaccination  for  11-12  year olds and  for  girls  as  young  as  9  years  old. The   Committee  
also  recommended  the  vaccination  of  13-26  year  old  females  who  have  not  been  
previously  vaccinated  or  have  not  completed  the  full  vaccination  series (10).In South 
Africa, the vaccines have been registered for use amongst girls aged 10 years and above (11). 
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Circumcision of males has been shown to reduce the risk of both genital HPV infection and 
cervical cancer in their female partners (12).This is because circumcised men are three times 
less likely to harbour HPV in their penis than uncircumcised men (12). Male circumcision 
therefore is also a primary preventative strategy for cervical cancer.  
The mainstay of secondary prevention of cervical cancer in developing countries is the use of 
cervical cytology which is able to detect premalignant conditions of the cervix years before 
they become malignant (1). Cervical cytology has a very high specificity (98-99%) but its 
sensitivity is low (50-75%) (1). Secondary preventive measures also include visual inspection 
of the cervix after acetic acid application (VIA) (1, 13), visual inspection of the cervix after 
Lugol’s iodine application (VILI) (13), and HPV typing (1). VIA has been shown to have a 
sensitivity of 55% in detecting high grade precancerous lesions while the sensitivity of VILI is 
said to be about 87% (13). The use of HPV typing for cervical cancer screening is still 
surrounded by many controversies. As a screening test to detect high grade squamous 
intraepithelial lesions (HGSIL), HPV typing has been shown to have comparable sensitivities 
to cytological screening. The major gain of HPV typing is seen in its very high negative 
predictive value (>97%) when it is used to triage patients with minor abnormalities on 
cytology. Given  the  fact  that  HPV  is  such  a  common  sexually  transmitted  disease  and  
persistent  infection  with  this  virus  has  serious  consequences, prevention  of  the  infection  
would  aid  in  bringing down the mortality and morbidity that results from cervical cancer. 
Even though  the low risk serotypes are responsible for 90% of genital warts (which are 
benign), presence of these lesions brings about  psychological and physical distress to the 
women and is an  economic burden to the health system as these women will have  to  be  
treated  and  followed  up until  the  lesions  are   cleared. 
The Health Belief Model (HBM) postulates that a person’s willingness to engage in a health-
seeking behaviour is influenced by perceived benefits, barriers, susceptibility, and seriousness 
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of the disease (14). Therefore a woman will only take a decision to modify her  lifestyle, be 
vaccinated against HPV or to participate  in  screening  services  for  cervical  cancer  if  she  
has  the right  information  pertaining  to  the  disease.  
 The HPV vaccine is available in the private sector in South Africa but not in state hospitals 
due to its high cost. There is no legislation for HPV vaccination in South Africa, and at present, 
its use remains voluntary. Therefore, it is important that the general population and especially  
those who are eligible for the vaccine be aware and understand the link between HPV and  
cervical cancer so that an informed decision can be made as to whether or not to vaccinate  
against this virus. 
 
1.2. LITERATURE   REVIEW  
1.2.1. Knowledge about HPV, HPV vaccine and cervical cancer 
 
Most  studies  have  shown  that  knowledge  about  HPV  and  cervical  cancer  among  
populations  is  low  and  inaccurate, though the range may be great. According  to  a  
systematic  review  of  39  studies  between  1992  and  2006  on  HPV  knowledge,  
knowledge  about  HPV  varied  from  13%-93% (15). 
  
1.2.1.1. Knowledge about HPV, HPV vaccine and cervical cancer among adult 
populations in developed countries 
In  the  United States, cross-sectional  data  from 3,026  women aged 18-75  years  responding 
to  the  2005  Health  Information  National Trends  Survey  was  analysed. Forty percent of the 
women in the study had heard about HPV. Less than half knew it caused cervical cancer. 
Knowledge  that  HPV  was  sexually  transmitted  and  that  it  caused  an  abnormal  pap  
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smear  was  64% and 79% respectively. Factors associated with having heard of  HPV  
included  younger  age, being  non-Hispanic, being white, having higher education, exposure  
to  multiple  health  information, and  having  tested  positive  for  HPV(16). 
 In a more recent American study (2009) in which knowledge about HPV and HPV vaccine 
was assessed in 4 different states among 202 adults in the general population, the majority 
(93%) had heard of HPV and 84% knew it caused cervical cancer. Eighty-seven  percent  had  
heard of HPV vaccine but only 18% knew the  vaccine  was  used  to  protect  against  cervical  
cancer. Interestingly in this study, although awareness of HPV vaccine was high among the 
population, the benefit of the vaccine was not clear to them. Levels of knowledge  about  HPV 
and  HPV vaccine  were  found  to  be different  in  the  different  ethnic  groups,  with  whites  
being more knowledgeable than blacks (17). 
In 2007, a survey to assess public knowledge and attitudes towards HPV vaccination was 
performed in Birmingham in the United Kingdom in which 420 participants aged 16-54 years 
were recruited. Very low knowledge scores were found. Out of 6 HPV related questions that 
were asked, 81% of participants did not get any of the answers correct and only 5.9% got 4 or 
more answers correct. Significant differences in knowledge were identified between  ethnic 
groups(whites being more knowledgeable than blacks), social class(only 1% of  the  manual 
workers were knowledgeable) and increasing age, with older people being more  
knowledgeable  than  younger ones(18). 
1.2.1.2. Knowledge among   South  African Women 
 
In a 2009  South  African  study, in Cape Town, 100  women attending an anti-retroviral  clinic  
were  randomly  selected  and  interviewed  about  their  knowledge  of  cervical  cancer  and  
Pap smears. Seventy-eight percent of them had never heard about cervical cancer, 59% 
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reported  having  had  a  pap  smear  and  about 40%  did  not  know  what  the pap  smear  was  
used  for (19).  
Another South African study based in the Western Cape between 2007 and 2008 looked at 
challenges towards HPV vaccination and vaccine uptake. Fifty in-depth interviews were 
conducted with health care providers, policy makers and community members (43 women aged 
21-57 years). Findings indicated that women’s knowledge and understanding of cervical 
cancer, the relationship between HPV and cervical cancer and purpose of cervical cytology 
tests was low. Even health care providers had varying levels of knowledge about current 
cervical cancer screening policies and the relationship between HPV and cervical cancer (20). 
In 2010, attitudes, knowledge and beliefs about HPV and cervical cancer among 86 females 
aged 18-44 years attending an ante-natal clinic in Johannesburg, South Africa were examined. 
Sixty-one percent of the participants had heard of cervical cancer, and only 29%  had  heard  of  
HPV;  of  those  who  had  heard  of  HPV, 79%   were  aware it was sexually  transmitted, 
33% were aware  there was  no  cure, 67%  knew it was a risk for cervical cancer and 75% 
knew condom use offered protection from HPV (21). 
1.2.1.3. Knowledge among students in the developed countries 
 
 A study was performed in the United States in 2008 among 1282 students in a large public 
university to assess knowledge of HPV and cervical cancer. Ninety-two percent of the  
participants had heard of  HPV but they were not aware of modes of transmission, ways  of  
prevention, commonality of the HPV  infection  and  its  role  in  cervical  cancer. Twenty- two 
percent of the participants had heard about the HPV vaccine. Eighty-five percent understood 
the risk factors for cervical cancer. However, some  risk  factors such as smoking and  poor  
nutrition were underestimated. In this study, the source of information about HPV was 
television (TV) commercials (66%), friends (38%), high school or college class (37%), and the 
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internet (32%). The majority  however  preferred  to  get  this  type  of  information  from  a  
physician (22). 
In a study performed in Italy in 2008 among 1348 women aged 14-24 years, 29% reported 
having heard that HPV is one of the commonest infections of the genital tract and three-
quarters of them identified that the infection is primarily transmitted sexually; half reported 
having heard of cervical cancer. Sixty percent were aware a cervical cytology was used to 
detect pre-cancerous changes in the cervix, 42% knew the HPV vaccine was a preventive 
measure for cervical cancer and 34% were aware condom use could prevent HPV infection and 
cervical cancer. Those who were more likely to have heard about HPV and HPV vaccine were 
older  women, also those who had one  parent in  the  health  profession and  those  who  had  a 
friend  or  family  member  diagnosed  with  cervical  cancer (23). 
In Portugal, a study was performed to assess knowledge of HPV and cervical cancer among 
1706 university students in 2010. This study showed that 55% had heard of HPV and 88% 
knew it was a risk factor for cervical cancer. Eighty-nine percent were willing to be vaccinated 
but only 13% stated prevention of cervical cancer as the reason for vaccination. Statistical 
differences in knowledge about cervical cancer were found between male and female  
(p< 0.001) and between Health science and non-Health Science students, (p< 0.001).There 
were no differences in the level of knowledge between those who were sexually active and 
those who were not(24). 
1.2.1.4. Knowledge among students in the developing world including South Africa 
 
There  are a number  of   studies  that  have  assessed  knowledge  about  HPV and cervical  
cancer  among  university  students in the  developing world. 
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 In 2009, a study to assess knowledge and health beliefs of cervical cancer screening was 
performed in Ghana among 140 college students whose ages ranged between 20-35 years. 
Eight percent were aware of the link between HPV infection and cervical cancer and 1% was 
aware smoking was a risk factor for cervical cancer. Sixty-four percent were aware cervical 
cytology was used to detect pre-cancerous changes in the cervix and 78% thought these 
changes could easily be cured (25). 
A Nigerian study that assessed awareness of cervical cancer and HPV vaccine and its  
acceptance  among  university  students  found  that  35% of  the students  knew  of  HPV, 53%  
had heard of cervical cancer and 74%  were willing to accept the  HPV vaccine. Age, medical  
education, HPV knowledge and awareness of  cervical  cancer  were  significant  predictors  of  
readiness  to  accept  the  HPV  vaccine (26). 
In a study at the University of the Transkei in the Eastern Cape in 1998 to assess cervical 
cancer awareness and risk factors among female university students, it was shown that 74% of 
the 260 participants in the study had heard of cervical cancer and 68% were able to identify 
HPV as a risk factor for cervical cancer. In this group knowledge of multiple sexual partners 
and early age of sexual debut as risk factors for cervical cancer was 57% and 34% respectively. 
Twenty-nine were aware cervical cancer was a preventable disease (27). 
Another study to assess cervical cancer awareness among female university students in South  
Africa at Mangosuthu University of Technology in Kwazulu Natal (2009) showed that less 
than half (42%) had heard of cervical cancer. Forty percent thought cervical cancer was a 
preventable disease, 42% had heard of a cervical cytology and 38% were aware it was used to 
prevent cervical cancer. Knowledge of risk factors for cervical cancer was low: 29% identified 
early age of sexual debut, 31% multiple partners, 18% smoking and 48% HPV infection as risk 
factors for cervical cancer. It was found  that  40% of  the  students  were  sexually  active and  
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among  them 28%  reported  having 2 or more  sexual  partners (28). There were no questions 
relating to knowledge of the HPV vaccines. 
 1.2.2. Risk factors for cervical cancer 
 
 Factors that increase the risk of cancer of the cervix among HPV DNA positive women  
include the use of oral contraceptives (for 5 or more years), high  parity (5 or more children), 
and previous exposure to sexually  transmitted  diseases such as Chlamydia trachomatis and 
Herpes Simplex Virus type 2 and infection with HIV(6). Smoking has been identified as a risk 
factor for developing cervical cancer. In a longitudinal study of 1485 women aged 15-19 years 
in the UK in 2009 to assess smoking as a risk factor for cervical intra-epithelial neoplasia, it 
was shown that current smoking intensity was associated with an increased incidence of high 
grade cervical intra-epithelial lesions (CIN) after controlling for cervical HPV status. Women 
who were positive for HPV infection and smoked 10 or more cigarettes per day were twice as 
likely as non-smokers to develop high grade CIN (9). 
1.2.3. Sexual behaviour, cervical cancer and HPV 
  
Sexual behaviour has been shown to be one of the factors that modify the risk of HPV  
infection and cervical cancer, particularly age at first sexual intercourse (AFSI)  and  number  
of  sexual  partners.  
In a 2006  study in the  Western Cape  in  South  Africa, information on age of  sexual  debut  
and number of lifetime partners was collected from 524 incident cervical cancer patients and 
1541 hospital controls. It was shown that women whose AFSI was <16 years had a relative risk 
(RR) of developing cervical cancer of 1.6 (95% CI 1.2-2.2) compared to those whose AFSI 
was 16 years or more. Women who had 4 or more sexual partners had a  RR of  1.7 (95% CI  
1.2-2.2) of  developing  cervical  cancer  compared to those who had  <4  sexual  partners. 
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Early  sexual  debut  in  this  group  was  associated with lower  education, higher number of  
sexual  partners and  alcohol  use. Having  a  greater number of  sexual partners  was associated  
with  younger age  of sexual  debut, being  black, being  single, higher education  level  and  
alcohol  use (4).  
In a study among 333 women aged between 22-53 years who were diagnosed with squamous  
cell carcinoma of the cervix between 1986 and 2004 in the Seattle-Puget South region in the  
United  States, results showed that AFSI influenced the age at which cervical cancer was  
diagnosed. The mean age of diagnosis with squamous cell cervical carcinoma was 3.1 years 
younger for women with AFSI < 15 years and 2.6 years younger for those with AFSI between 
15 and 18 years when compared with those with AFSI of 19 years or more (29).  
In the Netherlands a study was performed in 2007 to assess sexual behaviour and HPV 
prevalence among 2065 women aged 18-29 years, and factors associated with HPV prevalence 
were increasing age, current smoking, number of partners in the past 6 months and years of 
being sexually active with total number of partners being the most powerful predictor of HPV 
prevalence (30). 
Consistent use of  the  condom  by  male  partners  of  newly  sexually  active women has  been 
shown to reduce the risk of cervical and genital HPV infection (31). A longitudinal study 
among 82 female students at University of Washington was conducted between 2000 and 2005 
to evaluate whether use of condoms by their male partners reduced the risk of male to female 
transmission of HPV. Results showed that consistent condom use by the male partner reduced 
the risk of HPV infection and risk of developing cervical intra-epithelial lesions in the female. 
Incidence of HPV infection was 37.8 /100 patient years at risk among women whose partners 
used the condom all the time compared to 89.3 /100 patient years among those whose partners 
used it less than 5% of the time. Among those whose partners used the condom all the time, no 
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cervical intra-epithelial lesions were detected in 32 patient year at risk while 14 incident lesions 
were detected among 97 patient years at risk among those whose partners did not use the 
condom consistently (31). 
1.2.4. Sexual behaviour among adolescents in South Africa 
 
A nationally representative survey was carried out among 6217 women aged 15-24 years in all 
the nine provinces in South Africa in 2007 using the 2001 national census as a sampling frame. 
Sixty-seven percent reported being sexually active, 52% were on some form of contraception 
and of these, 26% were using the condom, 66% were using hormonal contraception and 7% 
were on dual methods (barrier and hormonal). In  this  sample, those  women  who  were  
students  or  employed  were  more  likely  to  use  contraception  than  those who were 
unemployed (32).  
In the 1998 study mentioned previously among university students in the Eastern Cape, 87% of 
them reported being sexually active and mean age of coitarche was 17 years. Fifty-five percent 
were on some form of contraception and of those, 9% used the condom, 50% used the 
Nuristerate injection and 32 % were taking the contraceptive pill. It was shown that  major  risk 
factors for cervical cancer present among these students included initiation of coitus before the 
age of 18 (53%), multiple partners (73%), male partners with other  partners (38%), previous  
history  of  sexually  transmitted  illnesses (42%) and vulval warts (4.7%) (27). 
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1.3. RATIONALE FOR THE STUDY 
 
In order to design health education messages about HPV, HPV vaccine and cervical cancer, it 
is crucial to determine the level of knowledge in the society and what gaps exist. Few studies in 
South Africa have assessed knowledge about HPV and cervical cancer and these studies were 
mostly in the general adult populations, although two studies have assessed knowledge 
amongst university students. The two studies that were performed among university students, 
include one in The Eastern Cape, at the University of Transkei in 1998 (27) and the other at 
Kwazulu–Natal in 2009 (28). There has been no such study in the Gauteng province. In 
addition, the mentioned studies focussed mostly only on knowledge of cervical cancer and 
HPV and not on the HPV vaccine.  
The intention of this study, therefore, was to assess knowledge of HPV, HPV vaccine and 
cervical cancer among female students at The University of Witwatersrand and the correlates 
of this knowledge. The other objective was to determine the sexual behaviour and practices 
that  might  put  them  at  risk  of  developing  cervical  cancer  later  in  life.  
This particular cohort was chosen because they were easy to access and also because they fall 
in an age group eligible for the HPV vaccine, a group where the risk of acquiring HPV 
infection is high and where multiple risk factors for persistent HPV infection and hence 
cervical cancer exist. 
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2. METHODS 
2.1. Study setting 
The study was conducted at The University of the Witwatersrand which is a multiracial, 
English medium university which has 5 faculties (Commerce, Humanities, Health Sciences, 
Science and Engineering). It is situated in Parktown in Johannesburg, South Africa. 
2.2. Study population 
This group consisted of female undergraduate students in 4 of the 5 female residences. Mixed 
residences were not included, since there was no clear indication where female and male 
students resided in mixed residences and the study was confined to female students only. There 
were no exclusion criteria. Students of all age groups, race, year of study, and programme 
enrolled were included. 
2.3. Sample size 
The researcher chose a convenient sample size of 200. Sample size calculation was not 
performed since no specific comparison was considered to be required to achieve significance.  
2.4. Study design 
This was a cross sectional descriptive study. 
2.5. Data collection 
Data collection was performed between the 24
th
September and the 31
st
 October 2010. Data was 
collected using a self-administered anonymous questionnaire in the English language (see 
Appendix A). 
Pilot testing of the questionnaire was performed using a sample of 15 female students. 
Responders were asked if there were difficulties with questions within the questionnaire or 
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with interpretation. None were identified. These piloted questionnaires were not included for 
analysis. 
Questionnaires for the study were distributed in 4 female residences at the University of 
Witwatersrand by the researcher.   
The questionnaires were distributed by sliding them under the doors of the rooms. Students 
were asked to place their filled in questionnaires in a sealed box that was placed in the 
reception area of every residence within a week of receipt. The boxes were designed to be deep 
with a slit just enough for submission to prevent interference. The completed questionnaires 
were then collected by the researcher from the box a week after they were distributed. The 
boxes remained in the reception area for another week before the researcher went to collect 
them. 
According to Ms Nicky Lowe, the Residence Development Manager at the University of 
Witwatersrand, students in these residence are mixed in terms of year of study, the programme 
in which they are enrolled, and race. 
2.5.1 The questionnaire 
Development of the questionnaire was guided by literature review and the study objectives. 
The principles of questionnaire development were adapted from previous authors (33-35), 
namely that the questions should be clear and understandable to the recipients, unambiguous 
and ethical, and that the questionnaire should be piloted to assess any ambiguity not originally 
recognised.  
Questions on knowledge about HPV and HPV vaccine were adapted from an American study 
which assessed knowledge of HPV and HPV vaccine in the general population (17). 
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 The questionnaire had a series of questions divided into 5 sections: (1)Socio-demographic 
information; (2)Sexual activity; (3)Knowledge of HPV; (4)Knowledge of HPV vaccine; 
(5)Knowledge of cervical cancer.  
Socio-demographic characteristics that were asked included age, year of study and programme 
of study, where the student accessed medical care, the profession of the bread winner in their 
family. Students were also asked whether they smoked. 
Sexual behaviour questions included whether the student was sexually active, age of sexual 
debut, number of sexual partners, whether those who were sexually active used contraception 
and which type of contraception they were using. 
Five specific questions were asked relating to HPV and three relating to the HPV vaccine. In 
the questions, participants were asked to choose the correct answer among the options that 
were given, or state lack of knowledge. 
Knowledge  of  cervical  cancer  was  assessed  by  asking  about  knowledge  of  risk  factors  
and  preventive  measures  including cervical cytology. Cervical cytology was referred to in the 
questionnaire as ‘pap smear’. Out  of  4  options,  students  were  asked  to  circle  which   they  
thought  were  risk  factors  for  cervical  cancer. There  was  a  similar  question  on  
preventive  measures  for  cervical  cancer.  
 2.6. Data analysis 
 Categorical variables were coded to facilitate data entry entered on a spread sheet. Analysis 
was performed using STATA 10 statistical package. Continuous variables were summarised 
using means and standard deviation for normally distributed data. Comparison of variables was 
performed using Pearson’s chi-square test. The Fisher’s exact test was used if observations 
within cells were less than 5. A p value <0.05 was considered significant.   
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2.7. Limitations 
As information pertaining to sexual behaviour is very sensitive, participants might not have 
given honest answers to questions that were asked. We attempted to minimise this by making 
the questionnaires anonymous and assuring the participants of maintaining confidentiality. The 
other limitation was the possibility of the participants looking up the answers in books or on 
the internet, therefore not giving a true picture of what their knowledge was.  
Information from these students cannot be generalised to the population at large because 
university students fall in a group of women more likely to know more about HPV and its role 
in cervical cancer than the general population. More studies will have to be performed 
focussing on the general population. 
2.8. Funding 
This research was funded by a Baragwanath Hospital research fund registered with the Wits 
Health Consortium, ‘Ukuhlola’. 
2.9. Ethics and protocol review  
Permission  to  conduct  the  study  was  obtained  from   the  Human  Research  Ethics  
Committee (medical), Ethics  Clearance  Certificate number M10654 (Appendix B), and from 
the  University’s  administration. The  protocol  was  also  reviewed  by  the Assessors  
Committee  in  the  Department  of  Obstetrics  and  Gynaecology. 
2.10. Consent 
 The  questionnaires  had  an  information  sheet  on  the  front  page  explaining  what  the  
study  was  about. It  was  agreed   that  by  returning  the  questionnaire, the  student  had  
given  consent  to  take  part  in  the  study (Information  sheet  included  in  Appendix C). 
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3. RESULTS 
3.1. Questionnaire completion 
Out of 860 questionnaires that were distributed, 192 students completed and returned the 
questionnaires. This gives a response rate of 22%. Two of the questionnaires were discarded 
because less than 50% of the questions were answered. Therefore 190 questionnaires were 
analysed. 
3.2. Demographics of the respondents 
The mean age of the respondents was 20.3 years (standard deviation 1.7). Distribution of the 
respondents’ ages is shown in Table 1. 
Table 1: Age distribution of the respondents  
    Age(years)     n(190)      %(100) 
    17-20      111       58 
   
    20-24        76       40 
   
    ≥25          3         2 
 
 
 
  
Majority of the participants were black, n=158 (83%) and the remaining were Indian, 
n=19(10%), white, n=6 (3%) and of mixed race, n=7 (4%) (Figure1). 
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Figure 1: Distribution by race 
 
Most of the respondents were enrolled in Faculties of Commerce (n=60, 32%), and Science 
including Engineering (n=48, 25%) while the rest were studying Humanities (n=43, 23%), 
Medicine (n=25, 13%), and other Health Science programmes (Physiotherapy, Pharmacy, 
Occupational  Therapy) (n=14, 7%) (Table 2). 
Table 2: Distribution of programme enrolled 
Programme n(190) %(100) 
Commerce   60    32 
   
Science(Non medical)   48    25 
   
Humanities   43    23 
   
Medicine   25    13 
   
   
Other Health Sciences   14     7 
 
Black 
83%(n=158) 
Indian 
10%(n=19) 
White 
3%(n=6) 
Mixed 
4%(N=7) 
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The  majority of the respondents were either in their 2
nd  
(n=60, 32%), or 3
rd
 year (n=54, 13%)  
of  study with  a  minority  in  4
th
  year  to  6
th
  year (Table  3). 
Table 3: Distribution by year of study  
   Year  of  study    n(190)    %(100) 
1st  year      47       25 
   
2
nd
  year      60      32 
   
3
rd
  year     54      28 
   
4
th
  year     24      12 
   
5
th
 year      3       2 
   
6
th
  year      2      1 
   
More than half (n=107, 56%), of the respondents accessed their medical care from private 
hospitals(Figure2). 
 
 Figure 2:Access to medical care 
 
Private hospital 
56%(n=107) 
State hospital 
40%(n=77) 
Both 
4%(n=6) 
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Seventy-five percent (n=143) of the respondents came from families which were classified as 
being of high socio-economic status i.e bread winner in upper management, mid-management 
positions or professionals. Twenty-five percent (n=47) were from families of low socio-
economic status (i.e small business owner, manual worker, unemployed (Table 4). 
Table 4: Distribution by socio-economic status 
          n(190)       %(100) 
High socio-economic 
status 
        143        75 
 
Low socio-economic 
status 
          47        25 
                    
   
                                                                        
Fifteen (8%) of the participants smoked while 175 (92%) did not (Figure 3). 
 
 Figure 3: Smoking status 
 
Yes 
8%(n=15) 
No 
92%(n=175) 
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3.3. Sexual practices among the study population 
Eighty–nine (47%) of the respondents were sexually active (Figure 4).  
 
 
 Figure 4: Proportion sexually active 
 
Mean age of coitarche was 18 years (standard deviation 1.6). Age at coitarche was16 years or less 
in 14% of the respondents (Table 5). 
Table 5: Distribution  of  age at coitarche 
Age at coitarche n(89) % 
13 -16 years 13 14 
17-20 years 67 76 
>20 years  9 10 
 
 
 The mean number of sexual partners was 3 (range 0-27). Twenty- one  percent  of  the  group  
had  had more  than  5 sexual  partners (Figure 5). 
47%(n=89) 
53% (n=101) 
yes No 
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Figure 5: Distribution of number of sexual partners 
 
3.3.1 Contraception use among the respondents 
Of those who were sexually active, 75 (83%) were on some form of contraception. Sixty (80%) 
used the condom only for contraception, 2(3%) used the injection only, while 13 (17%) used 
another form of contraception in addition to the condom [pill(n=9), injection(n=2) or loop (n=2)].  
Of the condom users, 37 (62%) reported to use it every time they had sexual intercourse, 16(27%) 
most of the time while 7 (11%) used it sometimes. 
3.3.2. Sexual behaviour and smoking 
There were a number of relationships which were noted between sexual behaviour and smoking. 
Smokers were more likely to be sexually active than non-smokers (p=0.04). Eighty seven percent 
of all the smokers (n=13) were sexually active vs 43% of all the non smokers (n=76)  (Table 6). 
 
 
79%(n=70) 
17%(n=15) 
4%(n=4) 
5 or less 6 to 10 11 to 27 
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Table 6: Relationship between being sexually active and smoking        
Sexually active              Smoking status P value 
  Yes   No                       
 n=15 (100%)   n=175 (100%)                   0.04 
Yes 13 (87)   76 (43)                         
No   2 (13)   99 (57)  
    
    
    
 There was a significant association between the age of coitarche and smoking (p=0.03). 
Smokers had sexual debut at a relatively younger age than non-smokers. Out of all smokers 
who were sexually active, 12 (92%) had sexual debut at the age of 18 years or less while for  
sexually active non-smokers, 46 (61%) had their sexual debut at the age of 18 years or less 
(Table 7). 
Table 7: Relationship between age at coitarche and smoking 
Age at coitarche          Smoking status      P value 
       Yes       No  
    
     n=13(100)      n=76(100)         0.03 
    
      < 18 years      12(92)       46(61)  
    
       ≥ 18 years        1(  8)       30(39)  
   
A significant association was seen between smoking and number of sexual partners 
(p=0.04).Smokers were more likely than non-smokers to have had more than 5 sexual partners 
(32%, of smokers vs 20% of non-smokers). (Table 8). 
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Table 8: Relationship between Smoking and Number of sexual partners 
No of partners                    Smoking status P value 
        Yes       No  
    
    
      n=13(100%)     n=76(100%) 
     0.04 
        ≤ 5        9(68)       61(80)  
    
         >5        4(32)       15(20)  
    
 
 
 
3.4. Knowledge about cervical cancer 
 Of  all  the  respondents  in  the  study, 180 (95%)  had  heard  of  cervical  cancer (Figure 6). 
  
Figure 6: Proportion of those who had heard about cervical cancer 
 
There was a trend for students from families of  high socio-economic status as assessed by  the 
profession of the breadwinner in the family to have heard about cervical cancer when  
compared to those from families of low socio-economic status although this difference did not 
n=180(95%) 
n=10(5%) 
Yes No 
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reach statistical significance, p=0.07. Another trend was seen in medical and other health 
science students where these students more likely to have heard of cervical cancer than the rest 
of the students, p=0.06. 
3.4.1. Source of information about cervical cancer 
The majority of the respondents (n=108, 60%) had heard of cervical cancer from the media 
(magazine, television, radio, newspaper and the internet), 28 (16%) obtained the information 
from medical or nursing staff. The others obtained their information from a lecture or class 
(n=70, 39%) or from a friend, parent or family member (n=44, 24%) (Table 9).  
There were overlaps in the source of information in that most of the respondents had more than 
one source of information. 
Table 9: Source of information about cervical cancer 
                n              % 
Family, friend or parent                 44                24 
   
Lecture / Class                 70                39           
   
Medical or Nursing staff                 28                 16 
   
Media(TV, Radio, Newspaper, 
Internet) 
              108                60 
     
 
3.4.2. Knowledge of risk factors for cervical cancer and its correlates 
Two of the 180 respondents who had heard of cervical cancer did not respond to the question 
on risk factors. Analysis is performed in 178 respondents. One hundred and three respondents 
(58%) identified early age of sexual debut as a risk factor for cervical cancer and 36 (20%) 
identified smoking as a risk factor for cervical cancer. Forty-eight (27%) did not know what the 
risk factors were (Figure 7). Most of the respondents identified more than one risk factor, hence 
the overlap. 
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Figure 7: Risk factors identified 
 
Out of 4 options that the respondents were asked to indicate which ones they thought were  risk 
factors for cervical cancer (3 of which were correct), 23 (13%) were able to identify all the 
three risk factors while 50 (28%) did not know what the risk factors were (Figure 8). 
 
Figure 8: Number of correct risk factors identified 
58%(n=103) 
52%(n=93) 
20%(n=36) 
27%(n=48) 
0% 
10% 
20% 
30% 
40% 
50% 
60% 
early Coitarche Multiple sexual 
partners 
Smoking Dont know 
3  correct 
n=23(13%) 
2 correct 
n=59(33%) 
1 correct 
n=46(26%) 
Don't know 
n=50(28%) 
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There was a significant association between knowledge about risk factors for cervical cancer 
and the different programmes enrolled (p=0.02). Highest levels of knowledge were found 
among students studying medicine and those in health science programmes while students 
studying humanities had the lowest levels of knowledge (Table 10). 
Table 10: Comparison of knowledge of risk factors and programme enrolled 
Programme Number of correct risk factors identified      P value 
       ≥ 2        1 Don’t know  Total(178)  
       n(%)       n(%)    n(%)       n     0.02 
Humanities       16(41)       10(26)    13(33)      39  
Medicine       18(72)         3(12)      4(16)      25  
Other Health 
Sciences 
      10(72)          2(14)      2(14)       14  
Science       29(63)          4(9)      13(28)       46  
Commerce       35(65)          1(2)      18(33)        54  
  
Significant differences in the knowledge of risk factors were also noted in the ethnic groups 
(p=0.02). Non-black students were more likely to be aware of the risk factors than black 
students. Fifty three percent (n=16) of non-black  vs  43% (n=66)  of  blacks were  aware  of at 
least 2  risk  factors  for  cervical  cancer. (Table 11). 
Table 11: Comparison of knowledge of risk factors and ethnic group 
Ethnic 
group 
        Number of correct risk factors identified         P value   
        ≥2      1 Don’t     
know  
Total(178)     
      
      
      n(%)     n(%)     n(%)    n(%)      0.02 
           
Black     66(43)   38(26)    44(30)   148(100)  
      
Non-black     16(53)     8(27)     6(20)    30(100)  
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Smokers were less knowledgeable about the risk factors than non-smokers. Twenty-one 
percent of smokers vs 48% of non-smokers were aware of at least 2 risk factors for cervical 
cancer, p=0.04(Table 12). 
Table 12: Comparison of knowledge of risk factors and smoking 
Smoker  Number of correct risk factors identified       P value 
     ≥2    1 Don’t 
know 
 Total  
       
     n(%)   n(%)   n(%)   n=178(%)     0.04 
       
Yes      2(21)   8(57)   3(22)  14(100)  
       
No    79(48)  28(23)  47(29) 164(100)  
      
 
There was no association between knowledge of risk factors and frequency of condom use 
(p=0.1) or number of sexual partners (p= 0.5). 
3.4.3. Knowledge of preventive measures and its correlates 
Out of all who had heard of cervical cancer, 88 (49%) thought it was a preventable disease. The 
majority of them identified the cervical cytology and delaying age of sexual debut as 
preventive measures for cervical cancer (n=59, 67% and n=54, 61% respectively) while 23 
(26%) thought not smoking would prevent cervical cancer. Again, there was overlap in that 
most of the respondents identified more than one preventive measure (Figure 9). 
 
 
29 
 
 
Figure 9: Preventive measures for cervical cancer identified 
 
Out of the seven options (5 of  which  were  correct), that respondents were asked to indicate  
which ones they thought  were the  preventive  measures  for  cervical  cancer, 17% identified 
all the  five preventive measures. Overall 42 (47%) of those who thought cervical cancer was 
preventable identified at least 3 out the 5 preventive measures. (See table 13). 
 
Table 13: Distribution of number of correct answers for preventive measures  
No. of correct answers     n=88 %(100) 
   Five     15  17 
    
   Four     10  11 
    
  Three     17  19 
    
  Two  27  31 
    
  One  19  22 
57%(n=50) 
67%(n=59) 
52%(n=46) 
26%(n=23) 
61%(n=54) 
Condom use Pap smear HPV vaccine Not smoking Delaying sex 
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There was a significant association between knowledge of preventive measures and the 
programme the student was enrolled in (p=0.01). Medical students and those students in other 
health science programmes were  more likely to have identified at least three out of the five 
preventive measures than students in other programmes (72% and 70% of  medical  and  health 
science students respectively  vs 29%, 39% and  45% of arts, science and commerce  students  
respectively)  (Table 14). 
Table 14: Comparison of knowledge of preventive measures and programme enrolled 
Programme                Number of correct answers P Value 
      ≥3      2         1      Total  
    n (%)    n(%)        n(%)    n=88(100%)  0.01 
Humanities   8(29)    6(28)        9(43)        21  
Medicine 13(72)     3(16)        3(16)        19  
Other Health 
Sciences 
  7(70)    3(30)          0        10  
Science   7(39)    8(44)           3(17)        18  
Commerce   9(45)    7(35)         4(20)        20  
 
There was no association between knowledge of preventive measures and number of partners 
(p=0.2) and smoking status of the student (p =0.2) 
3.4.4. Knowledge about cervical cytology  
Of those who had heard of cervical cancer, 146 (81%) had heard about cervical cytology. 
Eighty-eight (60%) were aware that its use was to screen for cervical cancer, 31 (21%) gave a 
wrong answer (to clean the womb, to check for sexually transmitted infections, to check for 
any gynaecological cancer and to check the vagina), and the remainder, 27(19%) did not know 
what cervical cytology was used for. 
Thirty four (18%) of the respondents had  had a cervical cytology test performed.  
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3.5. Knowledge about HPV 
Eighty one (43%) of the respondents had heard about HPV (Figure 10).  
 
 
 
Figure 10:Proportion of respondents who had heard of HPV 
Out of those who had  heard of  HPV, 50 (62%) were aware  HPV could cause genital warts, 
68 (84%) were aware it could cause cervical cancer, 46 (57%) were aware HPV was  common 
in women in their 20s, 48 (59%) were aware HPV is usually asymptomatic, 51(63%) were 
aware both men and women could get HPV, and 62 (76%) were aware it was sexually 
transmitted (Table 15).There was no significant association between  knowledge of  how  HPV  
is  transmitted and  frequency  of  condom  use (p=0.8). 
 
 
 
43%(n=81) 
57%(n=109) 
Yes No 
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Table 15: Distribution of answers to specific questions on HPV                                               
 Yes No Don’t know 
   n(%)  n(%)  n(%) 
HPV can cause 
genital warts 
50(62) 3(3) 28(35) 
HPV can cause 
cancer 
68(84) 3(3) 11(13) 
HPV is common in 
women in their 20s 
46(57) 4(4) 31(39) 
HPV is usually 
asymptomatic 
48(59) 7(9) 26(32) 
 Women only Both men &women Don’t know 
Who can get HPV 22(27%) 51(63%) 8(10%) 
 Sexually Don’t know  Wrong answer 
HPV transmission 62(76%) 11(14%) 8(10%) 
 
 
3.5.1. Source of information about HPV 
Of those who had heard of HPV, 46 (57%) had heard about it from a class or lecture, 33 (41%) 
from the media (magazine, television, newspaper or internet). Nine-teen (23%) had heard about 
it from a parent, family member or friend while 13 (16%) obtained the information from 
medical staff. The majority had more than one source of information. 
3.5.2. Correlates of knowledge about HPV 
Sexually active students were more likely to have heard about HPV than those that were not 
sexually active (50%, n=45, sexually active vs 35%, n=36) not sexually active (p=0.03) (Table 
16). 
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Table 16: Comparison of having heard about HPV and sexual activity 
Sexually 
active 
                Heard about HPV  P value 
     Yes     No   Total     
     
     n(%)    n(%)   n(%)    0.03 
     
  Yes 45(50) 44(50)  89(100)  
     
  No 36(35) 65(65) 101(100)  
     
 
Those who accessed medical aid from private hospitals were more likely to have heard of HPV 
than those who accessed it from state hospitals or both private and state hospitals (52% in 
private vs 30%  in state hospitals vs 33% in both, p=0.01) (Table 17). 
Table 17: Comparison of having heard about HPV and where medical aid accessed 
Medical 
care 
              Heard about HPV   Total(190)    P value    
 Yes  No    
     
   n(%)   n(%)     n(100%)     0.01 
     
Private 56(52) 51(48)     107  
     
State  23(30) 54(70)       77  
     
Both  2(33)   4(67)        6  
     
Students from high socio-economic status backgrounds were more likely to have heard of HPV 
than those from low socio-economic families (47% from high vs 30% from low socio-
economic status families had heard of HPV, p < 0.01) (Table 18). 
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Table 18: Comparison of having heard about HPV and socio-economic status  
Bread winner                        Heard about HPV   Total(190)         P value 
    Yes   No   
    n(%)   n(%)     n(100%)   < 0.01 
High 
socioeconomic 
status 
 
 
 
 67(47) 76(53)   143  
Low 
socioeconomic 
status 
 
 
 
14(30) 33(70)    47  
 
Medical students and students in other health science programmes were more likely to have  
heard about HPV than students in the other  programmes (92%  and 86% in medicine and 
health sciences respectively, vs 42%, 28%, and 23%  in humanities, commerce  and  science  
respectively) p<0.01(Table 19). 
Table 19: Comparison of having heard about HPV and programme enrolled 
Programme                     Heard about HPV     Total                 P value                  
  Yes No   
      
   n(%)  n(%) n=190(100%)  
      
Humanities  18(42) 25(23)   43    <0.01 
Medicine  23(92)   2( 8)   25  
      
Other Health 
Sciences 
 12(86)   2(15)   14  
      
Science  11(23) 37(77)   48  
      
Commerce  17(28) 43(72)   60  
     
There was no significant difference between having heard about HPV and frequency of 
condom use, p=0.7. 
Out of 5 specific questions about HPV that were asked, 57 (70%) of the respondents were 
correct in at least three questions. Medical and other health science students were more likely 
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to get at least 3 questions right than students from other programmes (87% and 92% in 
medicine and health sciences respectively vs 61%, 50 % and 59% in arts, science and 
commerce respectively), p=0.04 (Table 20). 
Table 20:  Comparison of number of correct answers and programme enrolled  
Programme    Number of correct answers out of 5    Total (n=81)               P value 
 ≥ 3   <3      
  n(%)   n(%)              0.04 
Humanities 11(61)   7(29)    18  
Medicine 20(87)   3(13)    23  
Health Science 11(92)   1(8)    12  
Science  5(50)   5(50)    10  
Commerce 10(59)   7(41)    17  
 
There was no association between knowledge of how HPV is transmitted and frequency of 
condom use (p=0.8). 
Knowledge  of  HPV  as  a  possible  cause  of  cancer  was  highest  among  medical  students 
(100%) and students  in  other  health  science  programmes  other  than  medicine  or  nursing 
(92%). This knowledge was lowest among those studying Commerce (65%),  p=0.008 (Table 
21). 
Table 21: Comparison between programme enrolled and knowledge of HPV as a cause of 
cervical cancer 
Programme             HPV can cause cancer                 Total              P  value     
 Yes No Don’t know     
 n(%) n(%) n(%) n(%)  0.008 
Humanities 15(83)  0 3(17) 18(100)  
Medicine 23(100)  0 0 23(100)  
Other Health 
sciences 
11(92) 1(8) 0 12(100)  
Science 8(73) 0 3(27) 11(100)  
Commerce 11(65) 1(6) 5(29) 17(100)  
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Knowledge of HPV as a possible cause of genital warts was highest among medical students 
(87%) and in students in other health science programmes (83%) and lowest among science 
students (27%) (p=0.001) (Table  22). 
Table 22: Comparison between programme enrolled and knowledge of HPV as a cause of 
genital warts 
Programme             HPV can cause genital warts 
 Yes No Don’t know Total(n=81) P value 
 n(%) n(%) n(%) n(100%)  0.001 
Humanities 8(44) 2(11) 8(44) 18  
Medicine 20(87) 0 3(13) 23  
Health 
Science 
10(83) 1(8) 1(8) 12  
Science 3(27) 0 8(73) 11  
Commerce 9(53) 0 8(47) 17  
      
There was no association between students in the different programmes and their knowledge of 
how HPV is transmitted (p=0.6), of who could get HPV (p =0.1) and of the fact that HPV 
could be asymptomatic (p=0.6). 
Forty-two (52%) of the respondents who had heard about HPV reported not being worried of 
getting HPV infection, 24(30%) were a little worried and 15 (18%) were very worried. The 
degree of worry about the infection was not significantly related to whether they were sexually 
active or not (p=0.1), the number of sexual partners they had had (p=0.2) or how frequently 
they used condoms (p=0.2). 
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3.6. Knowledge about HPV vaccine     
 Out of all the respondents, 51 (27%) had heard about the HPV vaccine (Figure11). 
 
Figure 11: Proportion heard about HPV vaccine. 
 Of those who had heard of the vaccine, 31 (61%) were aware that the recommended age group 
was 9-26 years, 34(67%) were aware it was only females who are eligible to get the vaccine, 
and 33(65%) were aware that the currently available vaccines protect against genital warts and 
cervical cancer (Table 23). 
Table 23: Distribution of answers to specific questions on HPV vaccine 
Recommended 
age group 
9-26 yrs 27-40 yrs 41-50 yrs Don’t know  
 31(61%) 12(23%) 0 8(16%)  
Who is eligible Males Females Both Don’t know  
 0 34(67%) 14(27%) 3(6%)  
Protective 
against cancer 
and warts 
True False Don’t know   
 33(65%) 6(12%) 12(23%)   
Yes 
27%(n=51) 
No 
73%(n=139) 
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3.6.1. Correlates of knowledge about HPV vaccine 
Black students were less likely to have heard of HPV vaccine than the non-black students (24% 
vs 41%), p=0.04 (Table 24). 
Table 24: Comparison of having heard about HPV vaccine and ethnic group 
Ethnic group        Heard of HPV vaccine 
 Yes No Total P value 
 n(%) n(%) n(%) 0.04 
Black 38(24) 120(76) 158(100)  
Non-black 13(41)  19(59)  32(100)  
 
 
Sexually active students were more likely to have heard about the vaccine than those who   
were not sexually active (35% vs 20%), p = 0.017(Table 25). 
Table 25: Comparison of sexually active with having heard of HPV vaccine     
Sexually active  Heard about HPV vaccine Total(n=190) P value 
  Yes No   
  n(%) n(%) n(%)   0.01 
Yes  31(35) 58(65)  89(100)  
No  20(20) 81(80) 101(100)  
     
There was a significant association between the programme in which the students were 
enrolled and awareness of the HPV vaccine. Students studying medicine or other health science 
programmes were more likely to have heard about the HPV vaccine (68% and 64% 
respectively) than the rest of the group, p <0.01(Table26). 
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 Table 26: Comparison of programme enrolled with having heard about HPV vaccine   
Programme  Heard about HPV vaccine Total(n=190) P value 
 Yes No   
  n(%)  n(%)  n <0.01 
Humanities 14(33) 29(67) 43     
Medicine 17(68) 8(32) 25  
Health Sciences   9(64) 5(36) 14  
Science   5(10) 43(90) 48  
Commerce   6(10) 54(90) 60  
 No  significant  differences  were  however  noted  in  knowledge  of  specific  aspects  of  the  
HPV  vaccine  among  students  in  the  various  programmes.  
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4. DISCUSSION 
 
Unfortunately, only 22% of the questionnaires distributed were completed and returned. The 
results might have been different if all the students had completed the questionnaire or had 
been interviewed. This low return rate might have created bias in our findings. From the outset 
of the study, however, it was anticipated that there would be a substantial ‘non return’ of the 
questionnaires and hence the aim of questionnaires to be analysed being set at 200 as stated 
previously in the Methodology. Other similar studies have however shown higher return rates. 
The study among university students in Kwazulu-Natal had a return rate of 97% (28) while the 
study in the Eastern Cape had a return rate of 74% (27). This may reflect different methods of 
distribution and collection.      
In our study, awareness about cervical cancer was found to be very high (95%). This is higher 
than the rates reported in most studies in and outside South Africa among the general 
population as well as amongst adolescents (28, 21, 24, 26). In South Africa, 22% of women 
interviewed in an ART clinic in Cape Town (19) and 61% of women attending an ante-natal 
clinic in a Johannesburg township (21) had heard of cervical cancer. Only 53% of students in a 
study conducted in a Nigerian university had heard of cervical cancer (26) and less than half 
(42.9%) of the students Mangosuthu University of Technology in KZN had heard of cervical 
cancer (28). In the University of Transkei in the Eastern Cape, 74% of the students had heard 
of cervical cancer (27). Lower levels of education in the studies performed among adult women 
in South Africa might explain their lower levels of awareness. Just over one third (36%) of the 
women in the Johannesburg ante-natal study had received tertiary education (21). It has been 
shown that higher level of education is associated with better knowledge about HPV and 
cervical cancer (16). 
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In our study, over a third of the students (39%) had heard about cervical cancer in a class or 
lecture. The KZN study was conducted in a university of technology which does not offer any 
health science programmes and this might explain their lower levels of awareness. The study in 
the Eastern Cape included medical students which may be why their level of awareness was 
relatively high. 
Another possibility is that levels of awareness about cervical cancer differ between the   
provinces reflecting how much health education is being given in the various provinces in 
South Africa.   
In our study, more than half (60%) of those who had heard of cervical cancer obtained the 
information through the media or internet and only 16% had heard about it from health 
professionals. The KZN study showed comparable findings where only 19% of the students 
reported having obtained the information from a health professional and in the Eastern Cape 
study, only 7% obtained the information from a clinic. However the KZN study showed a 
much lower proportion (19%) of students who had obtained the information from the media 
(28). Our study has shown the role that the media may have in educating women about health 
issues. Therefore, use of the media to disseminate health messages should be encouraged.  
Health professionals also have a role to play in educating women about cervical cancer. Our 
study however showed that a very small proportion of the respondents had obtained 
information about cervical cancer from a health professional. Health professionals may have to 
make greater efforts to educate their patients about cervical cancer regardless of age. The  
screening  policy  for  cervical  cancer  in  South  Africa is  to  perform  cervical cytology   
from  the  age of 30 years. The majority of the study populations in our study, the KZN, and 
Eastern Cape studies were less than 30 years old. It  is  possible  that  women  who  are  
younger  than  the  recommended  age  group  for cervical  cancer  screening  are  not  usually  
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educated  about the  cancer by health professionals. However, it is important to remember that 
most of the lifestyle modifications that could prevent cervical cancer should start well before 
screening for cervical cancer starts and therefore it is important to educate young women about 
such lifestyle issues. In addition, one study among adolescents in the US showed that 
adolescents prefer to get information on sexual heath from a health professional and not the 
media (22).   
In our study, just over half of those who had heard of cervical cancer were able to identify early 
coitarche (58%) and multiple partners (52%) as risk factors for cervical cancer. Only 20% 
knew smoking was a risk factor for cervical cancer. The level of awareness of these risk factors 
followed the same trend in the studies performed among university students in Eastern Cape 
and Kwazulu Natal. In the Eastern Cape, 34% of the respondents identified early age of sexual 
debut and 57% multiple partners as risk factors (27). In  KZN 28% and 31%  identified early 
sexual debut and multiple partners respectively as risk factors for cervical cancer and 18%  
identified smoking as a risk factor (28). The trend is similar in developed countries. One study 
in the US showed that adolescents underestimated smoking and poor nutrition as risk factors 
for cervical cancer (22). In our study, knowledge of risk factors for cervical cancer, particularly 
smoking was poor and this knowledge was particularly low among smokers. There is therefore 
a need to emphasise the role of smoking as a risk factor for the development of cervical cancer.  
There was no association between knowledge of risk factors and number of sexual partners in 
our study. This suggests that knowledge of risk factors did not actually result in behaviour 
change.  
Among those who had heard of cervical cancer, only 49% thought it was a preventable disease. 
Knowledge that cervical cancer is a preventable disease among KZN students was comparable 
to our findings (41%) (28), but was lower in the study in Eastern Cape (29%) (27), and in the 
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study performed in Johannesburg (21) among 18-44 year old women (39%). In our study, just 
over half of the 88 students who thought cervical cancer was a preventable disease thought 
condom use and HPV vaccine could prevent cervical cancer (56%, 52% respectively). The low 
level of knowledge of cervical cancer as a preventable disease is worrying. Women are less 
likely to use screening facilities, HPV vaccine or modify their lifestyles if they don’t fully 
understand what the benefits of doing this are. Therefore, in our health education messages, it 
is important to emphasise the fact that cervical cancer is a preventable disease.   
Even though a high proportion of the students (82%) had heard of cervical cytology, there were 
many misunderstandings about its use. Sixty percent knew it was used to screen for cervical 
cancer and the remaining 40% either gave a wrong answer or did not know what cervical 
cytology was used for. However, the  proportion  of cervical cytology  awareness  in our  study  
was  much  higher  than  the  KZN study which showed that only  42% of the students had 
heard of  pap  smear  and  only  38%  of  them  knew the use of  it (28). There  is  need  to give  
women  the  right  information  on  the  use  of cervical cytology  in order to increase uptake of 
this screening method.   
Less than half (43%) of the respondents in our study had heard of HPV. Most studies have also 
shown low levels of HPV awareness (15, 21, 24, 25, 26). In our study, sexually active students 
were more likely to have heard about HPV than those who were not sexually active. The 
findings in a Portuguese study were different where the level of awareness about HPV was not 
different between the two groups (24). It is a concern that those who are not sexually active are 
less aware of HPV. This is the group we should be focussing on in educating about HPV so 
that precautions can be taken to prevent the infection when they become sexually active. 
As in other studies (24, 26), our study also showed that health science students were more 
aware of HPV and cervical cancer than those in other fields. There is need to propagate 
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information on HPV to students in other programmes where sexual health is not part of their 
curricula using other forms of materials such as pamphlets. It may also be true that health 
science students are more naturally aware of health information than non health science 
students. 
It was shown in our study that students accessing medical care from private hospitals were 
more likely to have heard about HPV and HPV vaccine than those in state hospitals. Because 
of its high cost, the HPV vaccine is available only in private hospitals in South Africa. This 
might explain why students in private hospital were more likely to have been exposed to some 
information about HPV and the vaccine. However social surroundings, exemplified by access 
to private health care, could also play a role in knowledge about HPV in this group of women.   
Eighty four percent of the 81 students who had heard of HPV knew HPV was a possible cause 
of cervical cancer. In the study among ante-natal clinic attendees in Johannesburg, 67% of 
those who had heard of HPV were aware of the link between HPV and cervical cancer (21). 
Among  Ghanaian  university  students, only  8%  knew  of  this  link (25), 48% knew  about  
the  link  among  university  students  in  KZN (28) and 68%  among  students  in  Eastern 
Cape(27). The higher level of awareness of this link in our study than in other studies among 
university students can be explained by the fact that the topics on HPV and cervical cancer are 
part of the curricula among medicine and health science programmes and the other universities 
do not have health sciences faculties, though, as emphasized, health science students may have 
greater general health awareness as much as benefiting from formal health education.  
It is important for women to know about the link between HPV and cervical cancer. This 
would motivate them to practise preventive measures e.g condom use and the HPV vaccine. 
In our study, only 27% of the respondents had heard of the HPV vaccine. This is comparable to 
a study in the United States in 2008 among university students in which awareness about the 
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vaccine was 22% (22). Again, in our study, sexually active students were   more  likely  to have 
heard about the vaccine than those who were not sexually active. This is a concern because to 
achieve maximum benefit of the vaccine, it should be given to girls before they contract HPV 
i.e before they become sexually active. It would be a good thing for those  who are not sexually 
active to be made aware of the vaccine and its benefits so that decisions  to  vaccinate  can  be  
made  before  they  become  active. 
Just below half (47%) of the students in our study were sexually active. This rate is comparable 
to the KZN study that showed just over half (51%) of the students were sexually active (28). 
These proportions are however much lower than those that have been reported in other studies. 
In the study among students in the University of Transkei in Eastern Cape in 1998, 87% of 
students were said to be sexually active (27). In another study among a representative sample 
of 15-24 year olds from all the nine provinces in South Africa in 2007, 68% of the respondents  
reported being sexually active (29). It has been shown among South African youth that delayed 
sexual debut was associated with higher education attainment (32). This might explain why 
university students were less likely to be sexually active than youth in the general population. It 
is also possible that we are seeing a downward trend in sexual activity among the youth where 
young women are deciding to delay sex. This could be in response to the message of 
abstinence as a way of preventing HIV infection. The other explanation might be that the 
students were not entirely honest in disclosing their sexual activity owing to the sensitive 
nature of the subject. 
In our study, condom use among those that were sexually active was high - 97% of those who 
were on some form of contraception (83%) used the condom either alone or with another form 
of contraception. This is higher than what was shown among KZN where condom usage was 
81% (28). It is also much higher than what was reported in the 2007 survey of a national 
representative sample of South African 15-24 year old adolescents which showed that only 
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33% used the condom. In that study, it was shown that 67% were on hormonal contraceptives 
only (32). The study in the Eastern Cape University in 1998 also showed a very high rate of 
hormonal contraceptive usage (89%) with condom usage of only 10% (27). Our study showed 
very little hormonal contraceptive use (3%). This suggests a possible shift among the South 
African youth to use condoms for contraception rather than hormonal contraceptives, though 
other explanations, for example regional differences and differences of study groups, are 
possible. If there were an increase in condom use, this might be explained by health  education  
messages  that  advocate  for  condom  use  as  a  way  of  preventing  HIV. Use  of  condoms  
should  be  encouraged, not only  as  a preventive  measure  for  HIV  but  also  for  HPV and  
subsequently  cervical  cancer.  
In our study, over half (62%) of the respondents whose partners used the condom reported 
using it every time they had sexual intercourse. This is comparable to the KZN study that 
showed that 63% reported using the condom all the time (28). Although  this  proportion  is  
high, it would be better  if all  those using condoms used  them  all  the  time  in order  to  
achieve maximum benefit. Using it sometimes unsurprisingly offers less protection against 
HPV than using it all the time (31). 
Mean age at coitarche in our study was 18 years. This is comparable to other South African 
studies (4, 27, 28). Fourteen  percent  of  the  respondents  in  our  study  had  their  coitarche  
at the age of 16 years or less  and the  youngest  age of sexual debut was 13 years. Therefore, if  
we are to legislate HPV vaccination in South Africa, these ages will have to be borne  in mind. 
Young girl will definitely have to be vaccinated at least before they reach the age of 13 years. 
There is need for more studies on a larger scale to determine the age at which an average South 
African girl initiates sexual activity. Those students whose sexual debut was at the age of 16 
years or less are particularly at high risk of developing cervical cancer later in life (4) and 
would therefore benefit the most from this vaccine.  
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Twenty one  percent of  the  study  population  reported  having  more than 5 sexual  partners  
in  their  life time. This again increases their risk for developing cervical cancer (4). It  is  
particularly worrying that smokers reported earlier ages of sexual debut and a higher number of  
sexual partners than non-smokers and were less knowledgeable about risk factors for cervical  
cancer. All these facts put them at a particularly high risk for cervical cancer. Young  women  
who  smoke  should  therefore  be  a  subgroup  which  should  receive  special  attention  as  
far  as  health  education  messages  about  cervical  cancer  are  concerned. 
5. CONCLUSION 
Our study showed that knowledge of risk factors and preventive measures  for  cervical  cancer  
was  poor  even  though  awareness  of  the  cancer  was  high.  Less than half of the subjects 
knew that cervical cancer was a preventable disease and there were many misconceptions about 
the use of the cervical cytology. There is therefore a need to concentrate on educating women 
on the preventable nature of the disease. 
Knowledge of HPV was low in this study population. This  shows  that  even  though  these  
women were  aware  of  cervical  cancer, its link to HPV was  not  known to them. Sexual 
health messages have focused on preventing HIV while ignoring other sexually transmitted 
infections such as HPV. Health education messages about HPV can be incorporated in HIV 
messages since both infections are sexually transmitted and therefore have similar preventive 
measures. Knowing that using a condom for example, will protect against HPV, HIV and 
cervical cancer will perhaps motivate women to use it consistently. 
Even though the participants in our study were in an age group eligible for HPV vaccine and  
majority obtained their medical care in private hospitals where the HPV vaccine is currently  
available, very few of them knew about the vaccine. This means that even those women that  
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have access to the vaccine  don’t actually  know  about  it. Educating  young  women  about  
the  vaccine  might  help  improve  the  vaccine  uptake.     
Just  over  half  of  the  students  in  this  study  were  not  sexually  active. This  is  possibly  a  
reflection  of  the  positive  impact  of  the  abstinence  message  as  a preventive  strategy  for  
HIV. However, this  study  showed  that  among  those who were sexually  active, there is still 
a group that has remained resistant to health messages on HIV and  risky sexual  behaviour   
such as inconsistent condom  use  and  multiple  sexual  partners  still  exist  even  among  
educated  women. This puts these women at risk of HIV and HPV infection as well as cervical 
cancer.  There is therefore a need to continue giving health messages in the hope of further 
modifying these practices. 
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APPENDIX  A : QUESTIONNAIRE 
 
The following questionnaire is voluntary and entirely confidential. Note that your name does 
not appear on the form. Also note that your room number does not appear on the form. You 
may leave out any questions. This questionnaire is from the Dept of Obstetrics and 
Gynaecology at Wits. It is to help us to find out about what people know, and what their 
actual experience is. We actually do not know. Please fill out the form if you can. Please place 
the completed form in the big box by the door to the Res. The forms are hard to steal. Even if 
someone did…..they would have no idea whose forms they were. Thank you for helping. 
Please contact Dr Edridge(082-331-3656), or Dr Kalua(082-218-4738), if you would like to. 
Your enquiry will be completely confidential, and can be anonymous. Please place the filled in 
Questionnaire in the box within a week of receipt. 
 
Study number 
QUESTIONNAIRE 
A) SOCIO- DEMOGRAPHIC  CHARACTERISTICS 
1) Age   ................ 
2) Program  enrolled ............................................ 
3) Year  of  study ............................ 
4) Sex  ......................      (please circle)         Male         Female                     
5) Ethinicity    (please circle)            Black        White       Indian     Other  .............       
6) Where  do  you  access  medical  care ? (please circle)   
         Public Sector                     Private hospital 
7) What is  the  profession  of  the  bread  winner(s)  in  your family?  (please circle) 
    a) Upper  management / Big  business owner 
    b) Mid- Management/ Clerk / Junior public servant / Professional 
    d) Small business owner 
    e) Manual worker/tradesperson 
    e)  Other.....................................   
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8) Do  you  smoke?  (please circle)               Yes    /    No 
                                                     
B)  SEXUAL  HISTORY. 
9)  Have  you  ever  had  sex?    (please circle)       Yes    /  No 
10) If  yes,  how  old  were  you  when  you  first  had  sex?......... years. If not, leave blank 
11) How  many  sexual   partners  have  you  had? ........... 
12) Are  you  on  any  contraception?   (please circle)              Yes     /    No 
13) If  yes,  which  one? (please circle – you may circle more than one, or none) 
     a)Condom                   c) The  pill 
     b)The  injection          d)The  loop (IUCD) 
    
14) If  your answer  in  Quest 13  is  Condom,  how  often  do  you  use  it? ( please circle) 
    a) All  the  time 
    b) Most  of  the  time 
    c) Sometimes 
 
C)  KNOWLEDGE  ABOUT  HUMAN PAPILLOMA  VIRUS (HPV)  
15) Have   you  ever  heard  of   the  Human  papilloma virus  (HPV) ?   (please circle)    Yes  /  
No    
      (If  your  answer  is  Yes  proceed. If  No, please go  to section D) 
16) Who/What  was  the  source  of  the  information regarding HPV?   (please circle, circle 
more than one if you wish) 
     a) Parent 
     b) Classmate/Friend 
     c) Family  member 
     d) Medical  or  Nursing  staff 
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     e) Lecture/Class 
     f) Other  (please circle)         (a) Magazine        (b)TV       (c)Radio      (d)Newspaper     
17)  How  is  HPV  transmitted? 
..................................................................................................... 
18)  HPV can  cause  Cervical  Cancer               (please circle)     True       False     Don’t  know 
19)  HPV  can  cause  genital  warts                  (please circle)     True       False    Don’t  know      
20)  Who  can  become  infected  with  HPV?     (please circle) 
         a) Men  only 
         b) Women  only 
         c) Both  Men  and  Women 
         d) Don’t  know 
21)  HPV  is  common  in  women  in  their  20s  (please circle) 
            True        False        Don’t  know 
 
22) Most  people  with  genital  HPV  do  not  have  symptoms  of   the  infection    (please 
circle)  
           True         False        Don’t  know 
23) How  worried  are  you  of  getting  HPV?  (please circle)                        
         a) Not  worried 
         b) A  little  worried 
         c) Very  worried 
 
 
D )KNOWLEDGE  ABOUT  HUMAN  PAPILLOMA  VIRUS ( HPV)   VACCINE 
24)  Have   you   ever  heard  about   the  HPV  Vaccine?........(please circle)   Yes   /  No 
(If  your  answer  is  Yes,  proceed . If  No,  please go  to  Section  E) 
25)  For which  age  group(s)  is  it  recommended?   (please circle) 
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        a)  9 -26  years 
        b) 26 – 40  years 
        c) 41-50  years 
        d) Don’t  know 
26)  Who  is  eligible  for  HPV  vaccine?   (please circle) 
         a) Males 
         b) Females 
         c) Both  
         d) Don’t  know 
27) The  current  available  vaccines  can  protect  against  genital  warts  and  cervical            
cancers            (please circle)                                     True          False        Don’t  know 
 
 
E)  KNOWLEDGE  ABOUT  CERVICAL  CANCER 
28) Have  you  ever  heard  about  Cancer  of  the  Cervix?  (please circle) 
      Yes    /   No 
29) If  yes, source  of  information (please circle, you may circle more than one) 
     a) Parent 
     b) Classmate  /Friend 
     c) Family  member 
     d) Medical or  Nursing  personnel 
     e) Lecture / Class 
     e) other………..(please circle)     (a)Magazine      (b) TV       (c)Radio      (d) Newspaper 
30) Which  of  the  following  are  risk  factors  for  cancer  of   the  cervix?     (please circle, 
more than one if you like) 
     a) Early  age  of  onset  of  sexual  Intercourse 
    b) Stress 
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    c) Multiple  sexual  partners 
    d) Smoking 
    e) Don’t  know 
31) Have  you  ever  heard  of  a  Pap  smear   (please circle)        Yes   /  No 
32) If   Yes,  what  is  its use? If No please leave blank and pass to Quest 34 
............................................................................................................................................. 
............................................................................................................................................... 
33) Have  you  ever  had  a  Pap  smear         (please circle)           Yes  /  No 
34) Is  cancer  of  the  cervix  preventable?  (please circle)        Yes   /  No  /   Don’t  know 
35) If  Yes,  which  of  the  following  are  preventive  measures  for  this  type  of  cancer?   
(please circle, more than one if you like). If No do not answer 
     a) Using  Condoms 
     b) Good  hygiene 
     c) Pap  smear 
    d) Human  papilloma  virus (HPV)  Vaccine 
    e) Not  smoking 
    f) Exercise 
   g) Delaying  age  of  first  sexual  contact 
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APPENDIX  B: ETHICS CLEARANCE 
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APPENDIX  C: INFORMATION SHEET  
  
 INFORMATION   SHEET 
Hello,  my  name  is  Evelyn  Kalua. I  am  a  doctor  in  the  Obstetrics  and  Gynaecology  
Department   of   Chris  Hani  Baragwanath   Hospital.  We  are  conducting  a  research  to  
assess  how  much  students  know  about  the  Human  Papillomavirus  (HPV),  the  Human  
Papillomavirus   vaccine  and  cervical  cancer. We  are  finding   this   out    by  asking  
students   to  fill  in  a  questionnaire. This  questionnaire has  been  approved  by  The  Wits  
Human  Research  Ethics  Committee (Medical) and   is  being  distributed  to  all students  in  
the  residential  halls  at  Wits.  Questions  relating  to socio-demographic  characteristics, 
sexual history, and  questions  to  assess  how  much  you  know  about  HPV,  HPV  vaccine  
and  cervical  cancer  will be  asked.  This  information  will  help  us   determine  how  much  
the  youth  know  about  these  issues   and  help  us  in  designing  education  programmes  
regarding  these  topics. This  research  is  entirely  voluntary. In  other  words, a  person  who  
does  not  want  to  be  involved  does  not  have  to  complete  the  questionnaire. If  a  
person  does  agree  to  take  part  in  the  study  but  finds  certain  questions  that  they  do  
not  wish  to  answer, they  do  not  have  to  answer  those  questions, and   a  person  may  
withdraw  from  the  study if  at  any  time  they  wish  to.  Anyone  who  takes  part  will not  
gain  from  taking  part, nor  will they  be  paid  for  taking  part. 
All  answers  given, if  a  person  takes  part,  will  be   entirely   confidential i.e. nobody  else  
will  be  allowed  to  see  them. The   answer  sheets  will  not  have   any  name  on  them  and  
it  will  not  be  possible  to  identify  an  individual  from  their  answers  in  any  way.   By  
returning  the  questionnaire, it is accepted  that  consent  to  participate  in  the  study  has  
been  given. 
A  box  will  be  placed  at  the  reception  area  in  your  residential  hall.  After  completing  
the  questionnaire, please  place  it  in  the  box. Your answers will not be at all traceable to 
yourself. 
Please  do  not  hesitate  to  contact us on  the  following  numbers   after  completion of  the 
questionnaire  if  you  have  anxieties or  uncertainties: 0822184738 (Dr Kalua) or 
0823313656(Dr  Edridge). Your enquiries can be completely anonymous.  
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